Vitiligo is an autoimmune depigment disease results from extensive melanocytes
destruction. The destruction of melanocyte is thought to be of multifactorial causation …

Vitiligo is a multifactorial reversible skin disorder characterized by distinct white patches that
result from melanocyte destruction. Activated CXCR3+ CD8+ T cells promote melanocyte …

The skin serves as a physical barrier and an immunological interface that protects the body
from the external environment,–. Aberrant activation of immune cells can induce common …

Vitiligo is a complex disease whose pathogenesis results from the interaction of genetic
components, metabolic factors linked to cellular oxidative stress, melanocyte adhesion to the …

Background The treatment of vitiligo can be challenging. Up‐to‐date agreed consensus
recommendations on the use of topical and systemic therapies to facilitate the clinical …

Vitiligo is an autoimmune skin disorder caused by dysfunctional pigment-producing
melanocytes which are attacked by immune cells. Oxidative stress is considered to play a …

Vitiligo, the most common depigmenting disorder of the skin, is undergoing a period of
intense advances in both disease understanding and therapeutic possibilities leading the …

The Koebner phenomenon, also known as isomorphic reaction, refers to the development of
secondary lesions with the same clinical manifestations and histopathological …

Vitiligo is an acquired skin depigmentation disease involving multiple pathogenetic
mechanisms, which ultimately direct cytotoxic CD8+ cells to destroy melanocytes …

Vitiligo is an acquired immune-mediated disorder of pigmentation clinically characterized by
well-defined depigmented or chalk-white macules and patches on the skin. The prevalence …